-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Adjusts Price Target on Nevro to $46 From $49, Maintains Equal-Weight Rating

Morgan Stanley Adjusts Price Target on Nevro to $46 From $49, Maintains Equal-Weight Rating

MT Newswires · 01/06/2023 05:28